Panacos Pharmaceuticals, Inc.
PANC · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Market Cap | $1,636 | $2,411 | $3,748 | $4,212 |
| - Cash | $21,368 | $26,675 | $32,550 | $37,865 |
| + Debt | $18,206 | $19,350 | $19,333 | $19,311 |
| Enterprise Value | -$1,526 | -$4,914 | -$9,469 | -$14,342 |
| Revenue | $24 | $18 | $35 | $22 |
| % Growth | 33.3% | -48.6% | 59.1% | – |
| Gross Profit | $24 | $18 | $35 | $22 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$7,256 | -$8,906 | -$7,878 | -$8,960 |
| % Margin | -30,233.3% | -49,477.8% | -22,508.6% | -40,727.3% |
| Net Income | -$8,152 | -$9,742 | -$8,512 | -$9,349 |
| % Margin | -33,966.7% | -54,122.2% | -24,320% | -42,495.5% |
| EPS Diluted | -0.15 | -0.18 | -0.16 | -0.175 |
| % Growth | 16.7% | -12.5% | 8.7% | – |
| Operating Cash Flow | -$7,799 | -$7,770 | -$8,453 | -$7,125 |
| Capital Expenditures | -$3 | -$31 | -$47 | -$15 |
| Free Cash Flow | -$7,802 | -$7,801 | -$8,500 | -$7,140 |